|
|
 | | | |
- close
- close
- close
- close
Cornerstone Therapeutics (CRTX) |
QUOTE AND NEWS
StreetInsider.com
May 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cornerstone+Therapeutics%2C+Inc.+%28CRTX%29+Misses+Q1+EPS+by+5c/7437723.html for the full story.
Marketwire
May 15
Comment
CARY, NC -- (Marketwire) -- 05/15/12 -- Signs acquisition agreement with EKR Therapeutics, sharpening strategic focus on hospital and specialty markets Grows sales of core CUROSURF® and ZYFLO® products by 35% year over year Receives October 2012
Marketwire
May 14
Comment
CARY, NC and BEDMINSTER, NJ -- (Marketwire) -- 05/14/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) Cornerstone expands hospital product portfolio with cardiovascular products CARDENE® I.V. and RETAVASE® Transaction expected to be accretive in
Marketwire
May 8
Comment
CARY, NC -- (Marketwire) -- 05/08/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Tuesday, May 15, 2012, to discuss its financial results for the first quarter ended March 31,
Benzinga
Mar 13
Comment
Cornerstone Therapeutics
Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on
acquiring, developing and commercializing proprietary products for
the hospital, niche respiratory and related specialty markets,
announced today that the...
Marketwire
Mar 8
Comment
CARY, NC -- (Marketwire) -- 03/08/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) Strategic Products grow 7% year-over-year to $79.9 Million Acquisition of Cardiokine, Inc. completed Cash Balance at Year End approximately $74 Million
StreetInsider.com
Mar 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cornerstone+%28CRTX%29+Sells+Product+Rights+of+Factive+Tablets%2C+Spectracef+Family+to+Merus+Labs+%28MSLI%29%2C+Vansen/7248290.html for the full story.
Benzinga
Jan 26
Comment
Cornerstone Therapeutics (NASDAQ: CRTX) announced a new analysis published in the eFirst Pages section of the Pediatrics website reporting significant benefits in mortality rate and the need for redosing when treating neonatal respiratory distress...
Marketwire
Jan 4
Comment
CARY, NC -- (Marketwire) -- 01/04/12 -- Cornerstone Therapeutics (NASDAQ: CRTX) Cornerstone acquires worldwide rights to investigational therapy for hyponatremia Hyponatremia is one of the most common metabolic conditions affecting up to 6 million
Marketwire
Dec 5
Comment
CARY, NC -- (Marketwire) -- 12/05/11 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the hospital and respiratory markets, today
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
